Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

Item
http://www.wikidata.org/entity/Q39017038
Immune Cells in Cancer Therapy and Drug DeliveryThe new deal: a potential role for secreted vesicles in innate immunity and tumor progressionImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationInterferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironmentEGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.Strategies and developments of immunotherapies in osteosarcomaL-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcomaDysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.Drugs in early clinical development for the treatment of osteosarcoma.Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria.Description of the immune microenvironment of chondrosarcoma and contribution to progression.CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phaValproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates.Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.Myokines related to leukocyte recruitment are down-regulated in osteosarcoma.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
P2860

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.

Item
http://www.wikidata.org/entity/Q39017038
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Macrophages inhibit human oste ...... combination with interferon-γ.
@en
Macrophages inhibit human oste ...... combination with interferon-γ.
@nl
type
label
Macrophages inhibit human oste ...... combination with interferon-γ.
@en
Macrophages inhibit human oste ...... combination with interferon-γ.
@nl
prefLabel
Macrophages inhibit human oste ...... combination with interferon-γ.
@en
Macrophages inhibit human oste ...... combination with interferon-γ.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Macrophages inhibit human oste ...... combination with interferon-γ.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932